For functional validation we chose to focus on dlp, an mRNA target of TDP-43 that we previously identified in the ALS model of TDP-43 proteinopathy, and a known regulator of Wg signaling. The gene discussed is TXNL4B; the disease is amyotrophic lateral sclerosis.